Forbes contributors publish independent expert analyses and insights. I cover the cannabis industry, psychedelics, culture, and innovation. This article is more than 4 years old. We survived 2020.

Clara Burtenshaw had a personal interest in psychedelics that's now become her job. The 35-year-old lawyer has just started a venture fund in the UK, devoted to investing in psychedelics. Psychedelics ...

MindMed MMEDF released its full-year 2020 financial results. The company posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020. Its total assets at the end of the ...

MindMed posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020. Its total assets at the end of the reporting period were $85.6 million, counting $80.1 million in cash.

Out Nov. 3, In Waves and War focuses on a group of U.S. Navy SEALS who take Ibogaine, derived from a shrub native to Central ...

The VA is expanding psychedelic-assisted therapy trials for PTSD and depression at nine facilities, exploring new hope for ...

It’s said that science progresses “one gravestone at a time,” since major changes in theoretical perspective usually require a new generation or more to take hold. Psychiatry, in contrast, is in the ...

Psychedelic drugs are going mainstream fast, with research supporting their effectiveness in alleviating emotional problems. Scientists continue to revisit different psychedelics such as LSD, magic ...